A double blind, placebo-controlled study of Andrographis paniculata fixed combination Kan Jang in the treatment of acute upper respiratory tract infections including sinusitis.
A double blind, placebo-controlled, parallel-group clinical study was carried out to evaluate the effect of an Andrographis paniculata (N.) extract SHA-10 fixed combination, Kan Jang, in the treatment of acute upper respiratory tract infections, including sinusitis. Ninety-five individuals in the treatment group and 90 individuals in the placebo group completed the study according to the protocol. The medication was taken for 5 days. Temperature, headache, muscle aches, throat symptoms, cough, nasal symptoms, general malaise and eye symptoms were taken as outcome measures with given scores. The total score analysis showed a highly significant improvement in the verum group versus the placebo. This result applied to the group as a whole and to the sinusitis subgroups. The individual symptoms of headache and nasal and throat symptoms together with general malaise showed the most significant improvement while cough and eye symptoms did not differ significantly between the groups. Temperature was moderately reduced in the verum group. It can be concluded that Kan Jang has a positive effect in the treatment of acute upper respiratory tract infections and also relieves the inflammatory symptoms of sinusitis. The study drug was well tolerated.
Gabrielian
E S
ES
Erebuni, Medical Centre, Yerevan, Armenia.
Shukarian
A K
AK
Goukasova
G I
GI
Chandanian
G L
GL
Panossian
A G
AG
Wikman
G
G
Wagner
H
H
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D035685:Andrographis; D002908:Chronic Disease; D004224:Diterpenes / Q000627:therapeutic use; D004311:Double-Blind Method; D004338:Drug Combinations; D028001:Eleutherococcus; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy; D010936:Plant Extracts / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D012852:Sinusitis / Q000188:drug therapy*; D013997:Time Factors; D016896:Treatment Outcome
D004224:Diterpenes; D004338:Drug Combinations; D010936:Plant Extracts; C030419:andrographolide